FASTinov
FASTinov is a startup from the University of Porto specializing in rapid antimicrobial susceptibility testing kits. Their technology uses flow cytometry to deliver phenotypic antimicrobial susceptibility results within 2 hours, significantly faster than traditional methods. The company's mission is to provide innovative solutions to combat antimicrobial resistance by enabling faster and more precise diagnosis, thereby improving patient outcomes and supporting global health efforts.
Industries
Nr. of Employees
small (1-50)
Products
Phenotypic AST kit for bloodstream infections (Gram-negative and Gram-positive)
An in vitro diagnostic kit for performing phenotypic antimicrobial susceptibility testing directly from positive blood cultures, designed to produce susceptibility categorizations in under 2 hours.
Cytometry data analysis software for AST reporting
Software that processes flow cytometry data from AST assays and classifies bacterial susceptibility phenotypes to generate standardized reports.
Phenotypic AST kit for bloodstream infections (Gram-negative and Gram-positive)
An in vitro diagnostic kit for performing phenotypic antimicrobial susceptibility testing directly from positive blood cultures, designed to produce susceptibility categorizations in under 2 hours.
Cytometry data analysis software for AST reporting
Software that processes flow cytometry data from AST assays and classifies bacterial susceptibility phenotypes to generate standardized reports.
Expertise Areas
- Rapid phenotypic antimicrobial susceptibility testing
- Flow cytometry-based diagnostics
- Fluorescent probe assay development
- Clinical laboratory workflow automation
Key Technologies
- Flow cytometry
- Fluorescent probe-based assays
- Automated cytometry data analysis software
- Phenotypic antimicrobial susceptibility testing